Bontia Bio raises $1.25m to scale its animal flea treatment
In what’s being called a world first, Bontia Bio has developed a proprietary method of cloning and scaling the production of natural bioactive compounds that have a variety of uses.
Local biotech company Bontia Bio has completed a $1.25 million seed funding round, which will go towards scaling and developing anti-parasitic compounds that provide a natural alternative to treating pets with fleas.
The capital raising was led by Sprout Agritech, with support from Booster NZ’s
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
